FDA Inspection 1269298 — Aurisco Pharmaceutical Co., Ltd
The FDA completed an inspection of Aurisco Pharmaceutical Co., Ltd on Mar 21, 2025 in Tiantai, Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tiantai, Taizhou (China)